Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC

Worm-Like Nanoparticles Used to Kill Breast Cancer Cells

By BiotechDaily International staff writers
Posted on 26 Dec 2013
Image: Microscope images of the worm-like, rod-like, micelle- and vesicle-shaped nanoparticles (Photo courtesy of University of New South Wales, Australia).
Image: Microscope images of the worm-like, rod-like, micelle- and vesicle-shaped nanoparticles (Photo courtesy of University of New South Wales, Australia).
Cylinder-shaped nanoparticles have been shown to be seven times more lethal than traditional spherical ones when delivering drugs to breast cancer cells, an international team of researchers has discovered.

Moreover, the worm-shaped drug delivery vehicles are not anymore toxic to healthy cells according to the study, which was published December 2013 in the journal Polymer Chemistry. In this study, different polymeric nanoparticle shapes (including spherical micelle, cylindrical micelle, and vesicles) were examined, and the early findings suggest shape plays an important role in the cell uptake and toxicity response. The project was co-led by Assoc. Prof. Cyrille Boyer, from the University of New South Wales (UNSW) School of Chemical Engineering (Sydney, Australia) and the Australian Center for NanoMedicine (Sydney), and Prof. Thomas Davis from Monash University (Melbourne, Australia), and involved Dr. Bunyamin Karagoz from Istanbul Technical University (Turkey).

Developing nanoparticles to target drugs directly to specific regions of the body is an increasing field of medicine, and these new findings suggest changing the shape of nanoparticles could slash both treatment costs and side effects. “What we’ve discovered is that a different shaped nanoparticle can have a very different effect on cancer cells, even with the same amount of drug,” said Dr. Boyer. “However there is still a lot of work to do and we need to test the nanoparticles in vitro with a range of cancer cells.”

Research had earlier mostly focused on spherical drug delivery systems as they are easier to make, but this new study additionally offers a simple and inexpensive approach to devising three different nanoparticle shapes: vesicular, spherical, and tubular or “worm-like.”

The researchers are now looking into whether cylindrical shape nanoparticles also deliver drugs more effectively to other types of cancers.

Related Links:

University of New South Wales School of Chemical Engineering
Monash University
Istanbul Technical University



Channels

Genomics/Proteomics

view channel
Image: In mice, mitochondria (green) in healthy (left) and Mfn1-deficient heart muscle cells (center) are organized in a linear arrangement, but the organelles are enlarged and disorganized in Mfn2-deficient cells (right) (Photo courtesy of the Rockefeller Press).

Cell Biologists Find That Certain Mitochondrial Diseases Stem from Coenzyme Q10 Depletion

A team of German cell biologists has linked the development of certain mitochondrial-linked diseases to depletion of the organelles' pool of coenzyme Q10 brought about by mutation in the MFN2 gene, which... Read more

Drug Discovery

view channel
Image: Molecular model of the protein Saposin C (Photo courtesy of Wikimedia Commons).

Nanovesicles Kill Human Lung Cancer Cells in Culture and in a Mouse Xenograft Model

Nanovesicles assembled from the protein Saposin C (SapC) and the phospholipid dioleoylphosphatidylserine (DOPS) were shown to be potent inhibitors of lung cancer cells in culture and in a mouse xenograft model.... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Lab Technologies

view channel
Image: The FLUOVIEW FVMPE-RS Gantry microscope (Photo courtesy of Olympus).

New Multiphoton Laser Scanning Microscope Configurations Expand Research Potential

Two new configurations of a state-of-the-art multiphoton laser scanning microscope extend the usefulness of the instrument for examining rapidly occurring biological events and for obtaining images from... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.